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Abstract
Background: Recent evidence suggests that a substantial subgroup of the population who have a high-risk waist
circumference (WC) do not have an obese body mass index (BMI). This study aimed to explore whether including
those with a non-obese BMI but high risk WC as ‘obese’ improves prediction of adiposity-related metabolic outcomes.
Methods: Eleven thousand, two hundred forty-seven participants were recruited. Height, weight and WC were measured.
Ten thousand, six hundred fifty-nine participants with complete data were included. Adiposity categories were defined as:
BMIN/WCN, BMIN/WCO, BMIO/WCN, and BMIO/WCO (N = non-obese and O = obese). Population attributable fraction, area
under the receiver operating characteristic curve (AUC), and odds ratios (OR) were calculated.
Results: Participants were on average 48 years old and 50 % were men. The proportions of BMIN/WCN, BMIN/WCO, BMIO/
WCN and BMIO/WCO were 68, 12, 2 and 18 %, respectively. A lower proportion of diabetes was attributable to obesity
defined using BMI alone compared to BMI and WC combined (32 % vs 47 %). AUC for diabetes was also lower when
obesity was defined using BMI alone (0.62 vs 0.66). Similar results were observed for all outcomes. The odds for
hypertension, dyslipidaemia, diabetes and CVD were increased for those with BMIN/WCO (OR range 1.8–2.7) and
BMIO/WCO (OR 1.9–4.9) compared to those with BMIN/WCN.
Conclusions: Current population monitoring, assessing obesity by BMI only, misses a proportion of the
population who are at increased health risk through excess adiposity. Improved identification of those at
increased health risk needs to be considered for better prioritisation of policy and resources.
Background
Obesity is estimated to be the third largest contributor to
the overall burden of disease in Australia [1]. It is most
commonly assessed using the body mass index (BMI)
threshold of 30 kg/m2 or greater [2]. The limitations of
BMI have been discussed in the literature, including in a
review which suggested that it is time we move beyond
the use of BMI to assess obesity to actual measurements
of body fat mass [3]. However, methods such as under-
water weighing, deuterium dilution, dual-energy X-ray
absorptiometry, or bioelectrical impedance analysis reli-
ably estimate total body fat, but are too expensive and
time-consuming for population-level use.
Consequently, which anthropometric measure best iden-
tifies high-risk adiposity has been much debated. Various
alternative measures to BMI have been advocated to
improve estimates of adiposity and/or to provide better
prediction of ill-health, including waist circumference
(WC), waist-hip ratio, and waist-height ratio [4]. WC has
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generally been shown to be a better predictor of metabolic
risk and chronic diseases than BMI. This is likely due to a
combination of WC better identifying individuals at
increased health risk through greater total body fat, and by
also including those with central adiposity who are not
necessarily identified by BMI [5, 6]. However, the degree of
improvement in prediction of outcomes has not generally
been seen as sufficient to drive a shift from BMI to WC.
New data has recently emerged suggesting that 40–70 %
of the population classified as having high-risk WC have a
BMI that is below the obese range [7–9]. However, rela-
tively little is known about their associated health risks. In
order to determine if they are a group that should be rou-
tinely identified as obese, it is important to know whether
their health risks are greater than individuals with a non-
obese BMI and non-obese WC. The aim of our study was
to compare the metabolic health risks across different
combinations of BMI and WC categories in a population
of Australian adults, and to explore whether including
those with a non-obese BMI but a high risk WC with
those classified as ‘obese’ by BMI alone improves predic-
tion of adiposity-related metabolic outcomes.
Methods
Study population
The Australian Diabetes, Obesity and Lifestyle (AusDiab)
study methods and response rates have been described
previously [10]. In brief, a stratified cluster sample of 11,
247 adults aged ≥25 years was drawn from 42 randomly
selected census collector districts across Australia in
1999/2000. A total of 10, 659 participants were included
in this analysis. 588 participants (5.2 %) were excluded
due to missing data: BMI (n = 180); WC (n = 194); educa-
tion (n = 110); country of birth (n = 2); smoking status
(n = 212); TV viewing time (n = 92); CVD (n = 75); dys-
lipidaemia (n = 2); diabetes status (n = 169); and hyper-
tension status (n = 73) (numbers are not additive). There
was no difference in mean age between those with and
without missing data. Women were more likely to have
missing data than men (p < 0.001). This study was ap-
proved by the International Diabetes Institute Ethics
Committee and the Monash University Human Research
Ethics Committee. All participants gave written informed
consent.
Measurement of body mass index and waist
circumference
Height was measured to the nearest 0.5 cm without
shoes using a stadiometer. Weight was measured with-
out shoes and excess clothing to the nearest 0.1 kg using
a mechanical beam balance. BMI (kg/m2) was calculated
as weight (kg) /height (m)2 and categorized as: (i) non-
obese: <30 kg/m2; and (ii) obese: ≥30 kg/m2. WC was
measured at the point midway between the iliac crest
and the costal margin and the mean of two measures was
calculated. WC was categorized as: (i) non-obese: <102 cm
for men, <88 cm for women; and (ii) obese: ≥102 cm for
men, ≥88 cm for women [6]. Adiposity categories were
created using a combination of BMI and WC as fol-
lows: (i) BMIN/WCN; (ii) BMIN/WCO; (iii) BMIO/WCN;
and (iv) BMIO/WCO, where N = non-obese and O = obese.
Measurement of metabolic outcomes
In all states except Victoria, blood pressure was mea-
sured using a Dinamap® oscillometric blood pressure
recorder (General Electric Company, Milwaukee, WI,
USA). In Victoria, blood pressure was measured using a
standard mercury sphygmomanometer and adjusted
accordingly [11]. The average of two measures was used
in the analysis. Hypertension was defined as blood pres-
sure >140/90 mmHg or the use of antihypertensive
medication.
Blood samples were collected by venepuncture after
an overnight fast (≥9 h). All samples were centrifuged
on-site to separate plasma and serum, and were trans-
ported daily to a central laboratory where possible. If
transport to a central laboratory was not possible, sam-
ples were stored on-site in a freezer at −20 °C and then
transferred to a −70 °C storage facility within 1 to
2 weeks following collection [12]. Diabetes was defined
on the basis of fasting plasma glucose ≥7.0 mmol/l or
two-hour plasma glucose ≥11.1 mmol/l, or current treat-
ment with insulin or oral hypoglycaemic agents. Dyslip-
idemia was defined as triglycerides >2.0 mmol/l or high
density lipoprotein (HDL) cholesterol <1.0 mmol/l. Car-
diovascular disease (CVD) status was self-reported and
was defined as previous angina, stroke, and/or coronary
artery disease.
Measurement of covariates
Covariate data was collected using interviewer-administered
questionnaires. Educational attainment was categorized as:
(i) low: secondary school qualification or lower; (ii) middle:
attained trade or technician’s certificate, associate or under-
graduate diploma, or nursing or teaching qualification;
and (iii) high: attained a bachelor degree or post-graduate
diploma. Country of birth was dichotomised into Europid
and non-Europid. Physical activity was self-reported and
was categorised as: (i) inactive (0 min/week); (ii) insuffi-
cient (1–149 min/ week); and sufficient (≥150 min/ week).
Smoking status was categorised as: (i) current smoker; (ii)
ex-smoker; and (iii) non-smoker. Time spent watching
TV was used as a measure of sedentary behaviour and
was categorised as: (i) <2 h/day; (ii) 2–3.9 h/day; and
(iii) ≥4 h/day [13]. Information on alcohol consumption
and energy intake were collected using the Food Fre-
quency Questionnaire [14]. Alcohol consumption was
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dichotomised into ≤10 g/day and 10 g/day [15]. Energy
intake was analysed as a continuous variable.
Statistical analysis
To account for the clustering and stratification of the
survey design, and to adjust for non-response, the data
was weighted to match the age and sex distribution of
the 1998 estimated residential population of Australia
aged ≥25 years. The weighting factor was based on the
probability of selection in each cluster.
Population attributable fraction (PAF) was calculated
to determine the proportion of hypertension, diabetes,
dyslipidaemia and CVD that is attributable to obesity,
with obesity defined two ways: (i) obese according to
either BMI or WC; and (ii) obese according to BMI
alone. PAF was calculated using the formula:
PAF ¼ PE OR−1ð Þ1þ PE  OR−1ð Þð Þ
where PE = prevalence of obesity and OR = odds ratio.
Discrimination for obesity defined as obese BMI or
obese WC and obesity defined as obese BMI alone, with
each metabolic outcome, was determined using area
under the receiver operating characteristic curve (AUC)
and compared using Wald chi-squared tests [16]. An
AUC of 1.0 indicates perfect discrimination and AUC of
0.5 indicates that the discriminatory power of the pre-
dictor is no better than chance.
Logistic and linear regressions were used to explore the
relationships of adiposity categories with hypertension,
dyslipidaemia, diabetes and CVD, and with systolic blood
pressure, fasting total cholesterol and fasting plasma glu-
cose, respectively. Adjustments were made for age, sex,
education, country of birth, alcohol consumption, smok-
ing, and sedentary behaviour. Physical activity and energy
intake were initially included in the multivariate models,
however, they did not alter the relationship between adi-
posity measures and metabolic variables in this study and
were excluded from the final model to avoid over ad-
justment [17]. An interaction term was considered for
age (dichotomised using the approximate sample mean
age as <55 years and ≥55 years) and sex with the adi-
posity categories to test whether the relationship
between adiposity and our chosen metabolic variables
differed by age or by sex. As an interaction was found
with both age and sex, we analysed men and women,
and those aged <55 and ≥55 years separately.
To test whether any differences between BMI and
BMI plus WC classification was due to the larger pro-
portion of individuals classified as obese using BMI plus
WC compared to BMI alone, we shifted the BMI cut-
point to define obesity, such that the same proportion of
people would be identified as obese using BMI plus WC
and using BMI alone. The proportion identified as obese
using BMI plus WC (BMI ≥30 kg/m2 and/or WC ≥102 cm
for men and ≥88 cm for women) was 32 %, thus we exam-
ined the alternate BMI cut-point of ≥28.5 kg/m2 which also
identifies 32 % of the study population as obese.
All analyses were performed using STATA® 11.2
(STATA, college Station, TC, USA).
Sensitivity analysis
To test for any potential effect of different BMI and WC
cut-points for obesity for different countries of birth, a
sensitivity analysis was performed excluding 1007 non-
Europid participants.
Results
The characteristics of the study population are presented
in Table 1. The mean age of the participants was
48.2 years (SD 15.4 years) and 50 % were men. The
majority of the population had their highest level of
completed education as secondary school, and were
Europid, sedentary and non-smokers. The prevalence of
hypertension, diabetes, dyslipidaemia and CVD were 29,
7, 26 and 7 %, respectively. The mean BMI and WC
were 26.6 kg/m2 and 90 cm (96 cm for men and 84 cm
for women). Around two-thirds of the population were
non-obese by both BMI and WC (BMIN/WCN), while
12, 2 and 18 % were categorised as BMIN/WCO, BMIO/
WCN and BMIO/WCO, respectively. Figure 1 presents
the prevalence by sex.
The PAFs indicate that 16 % of hypertension, 32 % of
diabetes, 19 % of dyslipidaemia and 7 % of CVD was at-
tributable to obesity, with obesity defined using BMI
alone (Table 2). However, when obesity was defined
using a combination of BMI or WC, the PAFs were signifi-
cantly higher at 28, 47, 29 and 25 %, respectively. When
stratified by sex and by age, the PAFs were generally higher
in women compared to men, and in those aged <55 years
compared to those aged ≥55 years (Additional file 1:
Table S1). When we defined obesity using WC alone,
the findings were similar to when obesity was defined
using a combination of BMI or WC (data not shown).
Discrimination was significantly higher for obesity de-
fined using a combination of BMI or WC compared to
obesity defined using BMI alone (Table 2). Similar re-
sults were generally found when stratified by age and by
sex, except for CVD in those aged <55 years and dia-
betes in those aged ≥55 years, where no significant dif-
ference in AUC between the two obesity definitions was
observed (Additional file 1: Table S1).
Compared to those with BMIN/WCN, the odds for
hypertension, diabetes and dyslipidaemia were increased
in those with BMIN/WCO and those with BMIO/WCO
(Fig. 2 and Additional file 2: Figure S1), with the greatest
odds in the BMIO/WCO group. In contrast, the odds for
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CVD were similar for both the BMIN/WCO and BMIO/
WCO groups compared to those with BMIN/WCN. In all
analyses, greater odds ratios were observed for the
BMIO/WCN group compared to the BMIN/WCN group,
though the results were not statistically significant. The
magnitude of the odds ratios were generally higher in
women and in those aged <55 years compared to men
and those aged ≥55 years respectively. Systolic blood
pressure, fasting plasma glucose and total cholesterol
were elevated in both those with BMIN/WCO and those
with BMIO/WCO compared to those with BMIN/WCN
(Table 3 and Additional file 3: Table S2). Total choles-
terol, but not systolic blood pressure and fasting glucose,
was also elevated in those with BMIO/WCN compared
to those with BMIN/WCN.
When we used the alternative BMI cut-point for obes-
ity (≥28.5 kg/m2), the proportion of the population with
BMIN/WCO decreased from 12 to 7 %, while the propor-
tion with BMIO/WCN and with BMIO/WCO increased
from 2 to 6 % and from 18 to 23 %, respectively. The
proportion of hypertension, diabetes, dyslipidaemia and
CVD attributable to obesity defined using the alternative
BMI cut-point were higher compared to when obesity was
defined using the conventional BMI cut-point of ≥30 kg/
m2, though still lower than the proportions attributable to
obesity defined using a combination of BMI or WC
Table 1 Characteristics of the study population
Total BMIN/WCN BMIN/WCO BMIO/WCN BMIO/WCO
n = 10 659 n = 6 688 n = 1 594 n = 171 n = 2 206
Age (years) 48.2 (15.4) 46.1 (14.6) 56.2 (17.4) 42.1 (10.9) 51.6 (15.2)
Male sex, % 50.0 52.0 43.5 68.0 44.3
Education, %
Secondary school 37.0 33.7 44.2 35.1 44.7
Trade, technician’s certificate 32.2 32.1 31.9 33.5 32.8
Associate, undergraduate diploma, 11.7 12.3 10.6 11.0 10.5
nursing or teaching qualification
Bachelor degree, post-graduate 19.1 21.9 13.4 20.4 11.9
Europid, % 87.5 86.3 92.1 84.5 89.4
BMI (kg/m2) 26.6 (4.9) 24.2 (2.7) 27.8 (1.9) 31.0 (0.8) 34.3 (4.2)
Waist circumference (cm) 90.0 (13.6) 83.6 (9.5) 98.4 (8.0) 94.4 (5.8) 107.5 (11.2)
TV viewing time, %
<2 h/day 6.7 7.6 4.0 4.5 5.4
2- < 4 h/day 8.1 9.4 5.0 5.2 5.8
≥4 h/day 85.2 83.0 91.0 90.3 88.8
Alcohol consumption, ≤10 g/day (%) 62.1 59.4 64.5 63.6 70.5
Smoking status, %
Current smoker 16.4 17.0 16.5 21.2 13.4
Ex-smoker 25.9 23.2 33.1 24.1 31.3
Non-smoker 57.8 59.8 50.3 54.7 55.3
Systolic blood pressure (mmHg) 128.1 (18.3) 124.8 (16.6) 133.8 (21.4) 126.8 (12.1) 136.6 (19.5)
Diastolic blood pressure (mmHg) 70.8 (11.7) 69.4 (11.0) 71.9 (13.8) 72.9 (7.5) 75.2 (12.2)
Fasting plasma glucose (mmol/l) 5.5 (1.1) 5.4 (0.8) 5.7 (1.2) 5.6 (0.8) 6.0 (1.7)
Total cholesterol (mmol/l) 5.5 (1.1) 5.4 (1.0) 5.8 (1.2) 5.7 (0.8) 5.8 (1.2)
Hypertension, % 28.9 20.8 45.0 19.0 49.7
Diabetes, % 7.0 3.7 10.7 4.0 17.2
Dyslipidaemia, % 25.9 18.4 36.2 28.0 46.6
Cardiovascular disease, % 7.1 5.4 13.4 2.3 9.9
Data presented as mean (standard deviation) unless otherwise specified
Adiposity categories: BMIN/WCN: non-obese BMI and WC; BMIN/WCO: non-obese BMI, obese WC; BMIO/WCN: obese BMI, non-obese WC; BMIO/WCO: obese BMI
and WC
Hypertension defined as blood pressure ≥140/90 mmHg or on antihypertensive medication; diabetes defined as fasting plasma glucose ≥7.0 mmol/l or 2-hour
plasma glucose ≥11.1 mmol/l, or on oral hypoglycaemic medication or insulin; dyslipidaemia defined as triglycerides ≥2.0 mmol/l or HDL cholesterol <1.0 mmol/l;
CVD defined as previous angina, stroke and/or coronary artery disease
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(Table 2 and Additional file 1: Table S1). Similarly, while
the AUCs for obesity defined using the alternative BMI
cut-point were higher compared to obesity defined using
the conventional BMI cut-point, they were still signifi-
cantly lower than the AUCs for obesity defined using a
combination of BMI or WC (Table 2 and Additional file 1:
Table S1).
In the sensitivity analysis, including only Europid par-
ticipants did not significantly alter our results.
Discussion
In a population of Australian adults aged 25 years and
over, around one in three were classified as obese by
their BMI or their WC. The PAF and AUC for each
metabolic health outcome were higher when obesity was
defined as having either an obese BMI or obese WC, in-
dicating an improvement in the prediction of adiposity-
related metabolic outcomes, compared to when defined
as obese BMI alone. When compared to those who were
non-obese (BMIN/WCN), we found increased odds for
hypertension, diabetes, dyslipidaemia and CVD in those
with BMIN/WCO and those with BMIO/WCO. These
findings highlight the importance of looking beyond
BMI when assessing obesity in relation to health out-
comes across the population, as even those with a BMI
in the non-obese range may have elevated health risks
that may be as high as those with an obese BMI.
Population attributable fraction estimates the propor-
tion of disease that is attributable to a given risk factor,
and thus represents the proportion of disease that theor-
etically would not have occurred had the risk factor not
been present in the population [18]. In this study, we
found that the proportion of metabolic outcomes attrib-
utable to an obese BMI was significantly lower than the
proportion attributable to an obese BMI or WC com-
bined. This addition of WC to BMI appeared to be bene-
ficial as obesity defined using BMI alone had lower
discriminative ability for outcomes compared to obesity
defined using BMI and WC combined. Importantly,
these differences persisted even after we lowered the
BMI cut-point to increase the prevalence of the popula-
tion classified as obese by BMI alone to the same as that
identified by waist.
Our findings relating to obesity defined using BMI or
WC combined and obesity defined using WC alone were
very similar. However, we were unable to ascertain
whether this reflects no added advantage in combining
WC and BMI to define obesity rather than using WC
alone, or whether this is because in this study, there was
a modest number of participants with BMIO/WCN (2 %),
and therefore the individuals captured by defining obes-
ity as either an obese BMI or WC is virtually the same
as those captured by obese WC alone. Nevertheless,
these findings further highlight the importance of look-
ing beyond BMI when setting targets for the population.
Table 2 Population attributable fraction and area under the receiver operating characteristic curve for obesity defined using BMI
and WC
Obese by BMI or WC Obese by BMI Obese by alternative BMI
PAF (95 % CI) AUC (95 % CI) PAF (95 % CI) AUC (95 % CI) PAF (95 % CI) AUC (95 % CI)
Hypertension 28.3 (24.4, 32.1) 0.62 (0.61, 0.63) 15.7 (13.2, 18.1) 0.57 (0.56, 0.58) 21.7 (19.1, 24.3) 0.59 (0.58, 0.60)
Diabetes 47.4 (41.0, 53.1) 0.66 (0.65, 0.68) 32.4 (26.4, 37.9) 0.62 (0.60, 0.64) 36.2 (28.8, 42.9) 0.63 (0.61, 0.65)
Dyslipidaemia 29.0 (25.2, 32.6) 0.64 (0.63, 0.65) 18.8 (15.9, 21.6) 0.60 (0.59, 0.61) 26.8 (23.2, 30.1) 0.63 (0.62, 0.64)
CVD 24.5 (16.0, 32.2) 0.58 (0.56, 0.60) 7.3 (−1.0, 14.8) 0.53 (0.51, 0.54) 14.0 (5.1, 22.1) 0.54 (0.53, 0.56)
Obese by BMI or WC: BMI ≥30 kg/m2 or WC ≥102 cm for men and ≥88 cm for women; obese by BMI: BMI ≥30 kg/m2; obese by alternative BMI: BMI ≥28.5 kg/m2
PAF population attributable fraction, AUC area under the receiver operating characteristic curve, BMI body mass index, WC waist circumference, CVD
cardiovascular disease
Fig. 1 Prevalence of each adiposity category (BMIN/WCN: non-obese BMI and WC; BMIN/WCO: non-obese BMI, obese WC; BMIO/WCN: obese BMI,
non-obese WC; BMIO/WCO: obese BMI and WC) in: a Men, and b women
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By incorporating WC to identify those with high risk
adiposity and who should be targeted for intervention,
the potential exists to prevent more metabolic outcomes
in the population.
There has been little systematic analysis of the health
risks associated with different combinations of BMI and
WC. One study found that within each BMI category,
those with a high-risk WC were more likely to have
hypertension, diabetes, dyslipidaemia and the metabolic
syndrome compared to those with a normal-risk WC
[19]. This finding, while in line with ours, reported odds
ratios but not absolute risks, and without absolute risk,
it was not possible to determine whether the risk of dis-
ease in a person with high risk WC and obese BMI dif-
fered from a person with a high risk WC and non-obese
BMI. To our best knowledge, only one previous study
has found that, among individuals with a non-obese
BMI, those with a high-risk WC (BMIN/WCO) had an
increased risk for hypertension compared to those with
a non-high risk WC (BMIN/WCN) [20]. Thus our study
is among the first to demonstrate that by not regularly
identifying those with obesity exclusively according to
their WC, we are missing a group who appear to be at
an increased risk of metabolic outcomes.
Previous studies that have compared different an-
thropometric measures in relation to health outcomes
have generally concluded that while WC predicts meta-
bolic outcomes more strongly that BMI, the improve-
ments tend to be relatively modest and insufficient to
warrant a move away from BMI to WC [21, 22]. More
recently, there is evidence that BMI and WC have been
tracking differently over the past few decades. In a num-
ber of populations, greater increases in WC than BMI
have been observed, and WC has continued to increase
despite an apparent plateau in BMI trends [8, 23–27].
The potential implication of these trends is that even if
WC is only equivalent to or modestly better at predict-
ing metabolic outcomes than BMI, WC may be increas-
ingly capturing a different group of the population who
have increased health risks related to excess adiposity
than would be captured by BMI alone.
Taken together, our findings reinforce the importance
of WC measurement in obesity assessment to accom-
pany measures of BMI. Nevertheless, current population
monitoring for obesity and identification of high risk in-
dividuals in clinical practice still tend to rely heavily on
BMI [28, 29]. While some national weight management
guidelines suggest that health professionals consider
both BMI and WC, how to do so remains unclear within
the guidelines [29]. Further, there are no similar recom-
mendations for population health surveys. There needs
to be a systematic move away from the sole use of BMI
in obesity assessment towards identification of high risk
adiposity based on WC or a combination of adiposity
markers. Cut-points to identify high risk adiposity using
any anthropometric measure are arbitrary since associa-
tions between risk factors and diseases are continuous,
without discrete thresholds separating disease and no-
disease. Nevertheless, cut-points are valuable for population
Table 3 Multivariate linear regression for associations of adiposity categories with systolic blood pressure, fasting plasma glucose
and total cholesterol
Adiposity categories
BMIN/WCN Coefficient
(Reference)
BMIN/WCO Coefficient
(95 % CI)
BMIO/WCN Coefficient
(95 % CI)
BMIO/WCO Coefficient
(95 % CI)
Systolic blood pressure
(mmHg)
0.0 3.0 (1.5, 4.6) 3.3 (−0.5, 7.0) 8.7 (7.4, 10.0)
Fasting glucose (mmol/l) 0.0 0.2 (0.1, 0.3) 0.2 (−0.0, 0.4) 0.6 (0.5, 0.7)
Total cholesterol (mmol/l) 0.0 0.2 (0.1, 0.3) 0.4 (0.1, 0.7) 0.3 (0.3, 0.4)
Analyses were adjusted for age, sex, education, country of birth, TV viewing time, alcohol consumption and smoking status
Adiposity categories: BMIN/WCN: non-obese BMI and WC; BMIN/WCO: non-obese BMI, obese WC; BMIO/WCN: obese BMI, non-obese WC; BMIO/WCO: obese BMI
and WC
Fig. 2 The relationship between adiposity categories (BMIN/WCN:
non-obese BMI and WC; BMIN/WCO: non-obese BMI, obese WC; BMIO/
WCN: obese BMI, non-obese WC; BMIO/WCO: obese BMI and WC) with
hypertension, diabetes, dyslipidaemia and CVD, adjusted for age, sex,
education, country of birth, TV viewing time, alcohol consumption and
smoking status
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health monitoring, to classify and quantify likely disease
burdens, and to target health promotion.
A limitation to the current study is the small number of
participants in the BMIO/WCN category, which limited our
ability to ascertain their odds for disease compared to
those in other adiposity categories. Future studies in popu-
lations with a greater number of participants with BMIO/
WCN may help elucidate whether combining BMI and
WC for obesity assessment would be of benefit, or whether
simply moving to another single anthropometric measure,
such as WC, is sufficient.
Conclusion
In conclusion, one pitfall of current obesity monitoring is
that it may be missing a large proportion of the population
who have a high risk WC but a BMI below the obese
range, who are at increased health risk through excess adi-
posity. Our findings support the need for a systematic ap-
proach to obesity assessment including identification of
high risk adiposity based on other measures in addition to
BMI. This will improve identification of those at increased
risk of ill-health, which is important for better prioritisa-
tion of policy and resources.
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